Indies Pharma Jamaica Limited (JMSE:INDIES)

Market Cap	3.88B -1.4%
Revenue (ttm)	1.08B -11.1%
Net Income	128.86M -44.7%
EPS	0.10 -45.1%
Shares Out	1.33B
PE Ratio	30.29
Forward PE	n/a
Dividend	0.14 (4.82%)
Ex-Dividend Date	Apr 9, 2026

Volume	134,749
Average Volume	102,231
Open	n/a
Previous Close	2.800
Day's Range	2.800 - 2.910
52-Week Range	2.330 - 3.400
Beta	0.07
RSI	55.59
Earnings Date	Jun 12, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 64
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: INDIES

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.